I would say that's entirely possible. Pfizer-BioNTech is a global manufacturer. They have companies and sub-companies around the world. As to where that would be made and whether a company could leverage that to produce vaccines that are aimed for the Canadian market, I would have to refer to Public Services and Procurement Canada for the details of that and to Health Canada if it changes anything with regard to the regulatory approval.
